Human prion diseases in the United States

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Holman, Robert C ^a   Belay, Ermias D ^a   Christensen, Krista Y ^a   Maddox, Ryan A ^a   Minino, Arialdi M ^b   Folkema, Arianne M ^a   Haberling, Dana L ^a   Hammett, Teresa A ^a   Kochanek, Kenneth D ^b   Sejvar, James J ^a   Schonberger, Lawrence B ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CREUTZFELDT JAKOB DISEASE; DEATH CERTIFICATE; DISEASE DURATION; DISEASE SURVEILLANCE; FEMALE; HUMAN; INCIDENCE; MALE; MORTALITY; UNITED STATES; VARIANT CREUTZFELDT JAKOB DISEASE; ADOLESCENT; CHILD; HEALTH SURVEY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PRION DISEASE;

ANIMALIA; BOVINAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; POPULATION SURVEILLANCE; PRION DISEASES; UNITED STATES; YOUNG ADULT;

EID: 77649141798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008521     Document Type: Article

References (49)

1. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol. 1999; 53: 283-314.
2. Belay ED, Schonberger LB. The public health impact of prion diseases. Annu Rev Public Health. 2005; 26: 191-212.
3. Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol. Jan 19 2009.
4. Belay ED, Schonberger LB. Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med. Dec 2002; 22(4): 849-862, v-vi.
5. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med. Apr 18 1991; 324(16): 1091-1097.
6. Prusiner SB. Prions. Proc Natl Acad Sci U S A. Nov 10 1998; 95(23): 13363-13383.
7. Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain. Jun 2003; 126(Pt 6): 1333-1346.
8. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. Aug 1999; 46(2): 224-233.
9. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003; 66: 255-265.
10. Belay ED, Holman RC, Schonberger LB. Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis. Sep 15 2005; 41(6): 834-836.
11. Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science. 2001; 294: 1726-1728.
12. Belay ED, Maddox RA, Gambetti P, Schonberger LB. Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology. Jan 28 2003; 60(2): 176-181.
13. Belay ED, Sejvar JJ, Seih WJ, Wiersma ST, Zou WQ, et al. Variant Creutzfeldt-Jakob disease death, United States Emerg Infect Dis. 2005; 11: 1351-1354.
14. Ghosh S. Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease. Adv Drug Deliv Rev. Apr 19 2004; 56(6): 915-920.
15. Zou S, Fang CT, Schonberger LB. Transfusion transmission of human prion diseases. Transfus Med Rev. Jan 2008; 22(1): 58-69.
16. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis. Jan-Feb 2001; 7(1): 6-16.
17. U.S. Department of Health and Human Services. Vital statistics mortality data, multiple cause detail, 1979-2006. Public use data tape contents and documentation package. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics, 2008.
18. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death, based on recommendations of the ninth revision conference. Vol. 1, 1975: Geneva: World Health Organization; 1977.
19. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10), Vol 1 Geneva: World Health Organization; 1992.
20. National Center for Health Statistics. Public Use Data Tape Documentation - Multiple Cause of Death for ICD-9 1981 Data; 1984.
21. National Center for Health Statistics. Public Use Data Tape Documentation - Multiple Cause of Death for ICD-9 1982 Data. 1985.
22. DHHS/CDC/NCHS.Mortality Data from the National Vital Statistics System, SuperMICAR. http://www.cdc.gov/nchs/about/major/dvs/super.htm Accessed 2/27/2009.
23. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA. Nov 8 2000; 284(18): 2322-2323.
24. Gajdusek D. Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidoses. Virology. Vol 2. 3rd ed. Philadelphia: Lippincott-Raven; 1996: 2851-2900.
25. Bureau of Census: Intercensal estimates of the Population by Age, Sex and Race: 1979-2006. Washington, Bureau of Census, 2008.
26. Census regions and divisions of the United States. United States Census Bureau. http://www.census.gov/geo/www/us-regdiv.pdf. Accessed September 22, 2009.
27. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People Statistical Notes, no. 20. In: National Center for Health Statistics, Hyattsville, MD; 2001.
28. Heron M, Hoyert L, Murphy S, Xu J, Kochanek K, et al. Deaths: Final data for 2006. National Vital Statistics Reports vol 57 no 14. Hyattsville, Maryland: National Center for Health Statistics; 2009.
29. Kleinbaum D, Kupper L, Muller K, Nizam A. Applied Regression Analysis and Other Mulivariable Methods - 3rd Edition. Pacific Grove, CA: Duxbury Press; 1998.
30. CDC. Variant Creutzfeldt-Jakob Disease. http://www.cdc.gov/ncidod/dvrd/ vcjd/index.htm. Accessed 3/2/2009.
31. CDC. vCJD (Variant Creutzfeldt-Jakob Disease) Archive: News and Highlights. http://www.cdc.gov/ncidod/dvrd/vcjd/other/vCJD-112906.htm. Accessed 4/8/2009.
32. Will RG, Alper MB, Dormont D, Schonberger LB. Infectious and sporadic prion diseases. In: Prusiner SB, ed. Prion biology and diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2004: 629-672.
33. Klug GM, Boyd A, Lewis V, Douglass SL, Argent R, et al. Creutzfeldt-Jakob disease: Australian surveillance update to December 2005. Commun Dis Intell. 2006; 30(1): 144-147.
34. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. May 10 2005; 64(9): 1586-1591.
35. Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology. 1995; 14(4): 174-181.
36. Kovanen J, Haltia M. Descriptive epidemiology of Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand. Jun 1988; 77(6): 474-480.
37. Maytenyi K. Creutzfeldt-Jakob disease in the last 5 years in Hungary. Eur J Epidemiol. Sep 1991; 7(5): 457-459.
38. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, et al. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. Sep 1988; 51(9): 1113-1119.
39. Elsaadany S, Semenciw R, Ricketts M, Mao Y, Giulivi A. Epidemiological study of Creutzfeldt-Jakob diseased disease death certificates in Canada, 1979-2001. Neuroepidemiology. 2005; 24(1-2): 15-21.
40. Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis. Oct-Dec 1996; 2(4): 333-337.
41. de Silva R, Findlay C, Awad I, Harries-Jones R, Knight R, et al. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J. Sep 1997; 73(863): 557-559.
42. BSE (Bovine Spongiform Encephalopathy, or Mad Cow Disease). http://www.cdc.gov/ncidod/dvrd/bse/index.htm Accessed 7/1/2009.
43. World animal health situation. http://www.oie.int/eng/info/en-esbru.htm. Accessed 11/6/2008.
44. The National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU); Creutzfeldt-Jakob Disease Surveillance. http://www.cjd.ed.ac.uk/index.htm. Accessed 3/31/2009.
45. Davanipour Z, Smoak C, Bohr T, Sobel E, Liwnicz B, et al. Death certificates: an efficient source for ascertainment of Creutzfeldt-Jakob disease cases. Neuroepidemiology. 1995; 14(1): 1-6.
46. CDC. Surveillance for Creutzteldt-Jakob Disease - United States. MMWR. August 9, 1996 1996; 45(31): 665-668.
47. National Prion Disease Pathology Surveillance Center. http://www.cjdsurveillance.com. Accessed 4/3/2009.
48. Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. Jun 2008; 63(6): 697-708.
49. Comoy EE, Casalone C, Lescoutra-Etchegaray N, Zanusso G, Freire S, et al. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE. 2008; 3(8): e3017.